Form 4: IRADIMED Director Converts RSUs to Common Stock

IRADIMED Director Hilda Scharen-Guivel converted 905 restricted stock units into common stock, increasing her direct beneficial ownership.

Summary

• Hilda Scharen-Guivel, a Director of IRADIMED CORP (IRMD), reported a transaction on December 11, 2025.
• She converted 905 Restricted Stock Units (RSUs) into common stock.
• These RSUs were initially received on December 11, 2024, under the company's 2023 Equity Incentive Plan.
• The RSUs vest in two equal annual installments, with the first installment vesting on December 11, 2025.
• Following this conversion, Scharen-Guivel directly beneficially owns 8,598 shares of common stock.
• She also directly beneficially owns 906 derivative securities, specifically Restricted Stock Units, which are yet to vest.

Sentiment

Score: 7

Explanation: The filing reports a routine conversion of restricted stock units by a director, which is a positive sign of insider ownership and execution of a pre-approved equity compensation plan. It does not indicate any new strategic developments or significant financial changes, hence a moderately positive sentiment.

Positives

• Director's beneficial ownership of common stock increased, aligning her interests with shareholders.
• The transaction is part of a pre-existing equity incentive plan, indicating planned compensation and retention strategy.

Future Outlook

The remaining 906 Restricted Stock Units are expected to vest in a future installment, completing the two equal annual installments as per the grant terms.

Industry Context

This is a routine insider transaction report reflecting standard executive compensation practices involving equity incentives, which are common across many industries to align management interests with shareholder value.

Comparison to Industry Standards

• Equity incentive plans and RSU grants are standard compensation practices for directors and executives in publicly traded companies, aligning their interests with shareholders.
• The vesting schedule of two equal annual installments is a common structure for such grants, promoting long-term retention and performance.

Corporate Governance

Related Party Transactions

• The transaction involves a director (Hilda Scharen-Guivel) and the company's equity, which is a standard related party transaction within the scope of executive compensation.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased common stock ownership.
• Employees: No direct impact mentioned for general employees.

Next Steps

• The remaining 906 Restricted Stock Units are expected to vest in a future installment.

Key Dates

Recommendation

This Form 4 filing details a routine conversion of Restricted Stock Units by a director as part of an existing equity incentive plan. It reflects standard compensation practices and an increase in the director's direct common stock ownership, which is generally a positive signal of alignment. However, it does not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

IRADIMED CORP, IRMD, Form 4, Insider Trading, Restricted Stock Units, Equity Incentive Plan, Director Ownership, Common Stock Conversion